journal article·2023-07-01Open access

Microphysiological systems to study colorectal cancer: state-of-the-art

Pedro Ramos, Mariana R Carvalho, Wei Chen, Le-Ping Yan, Chang-Hua Zhang, Yu-long He, Rui L Reis, Joaquim M Oliveira

Biofabrication· Volume 15· Issue 3

Abstract

Abstract Basic pre-clinical research based on 2D cultures have been very valuable in colorectal cancer (CRC) research but still have failed to improve patient prognostic outcomes. This is because they simply do not replicate what happens in vivo, i.e. 2D cultured cells system cannot replicate the diffusion constraints usually found in the body. Importantly, they also do not mimic the dimensionality of the human body and of a CRC tumour (3D). Moreover, 2D cultures lack the cellular heterogeneity and the tumour microenvironment (TME) such as stromal components, blood vessels, fibroblasts, and cells of the immune system. Cells behave differently whether in 2D and 3D, in particular their different genetic and protein expression panels are very different and therefore we cannot fully rely on drug tests done in 2D. A growing field of research based on microphysiological systems involving organoids/spheroids or patient-derived tumour cells has become a solid base for a better understanding of the TME and as a result is a step towards personalized medicine. Furthermore, microfluidic approaches have also started to open possibilities of research, with tumour-on-chips and body-on-chips being used in order to decipher complex inter-organ signalling and the prevalence of metastasis, as well as CRC early-diagnosis through liquid biopsies. Herein, we focus on the state-of-the-art of CRC research with emphasis on 3D microfluidic in vitro cultures—organoids, spheroids—drug resistance, circulating tumour cells and microbiome-on-a-chip technology.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Cancer Cells and Metastasis · Cancer Genomics and Diagnostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Cancer care: assuring quality to improve survival
2. Colorectal cancer statistics | WCRF International
3. Microphysiological systems to recapitulate the gut–kidney axis10.1016/j.tibtech.2020.12.001 ↗
4. Microfluidic organs-on-chips10.1038/nbt.2989 ↗
5. Reconstituting organ-level lung functions on a chip10.1126/science.1188302 ↗
6. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro10.1038/nmeth.3697 ↗
7. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment10.1039/c3ib40049b ↗
8. Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip10.1038/s41551-017-0069 ↗
9. Gut-on-a-chip microenvironment induces human intestinal cells to undergo villus differentiation10.1039/c3ib40126j ↗
10. Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury10.1039/C4LC00371C ↗
11. Bone marrow-on-a-chip: long-term culture of human haematopoietic stem cells in a three-dimensional microfluidic environment10.1002/term.2507 ↗
12. Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip10.1371/journal.pone.0150360 ↗
13. Modelling cancer in microfluidic human organs-on-chips10.1038/s41568-018-0104-6 ↗
14. The third dimension: new developments in cell culture models for colorectal research10.1007/s00018-016-2258-2 ↗
15. Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment10.1098/rsif.2017.0137 ↗
16. Advances in on-chip vascularization10.2217/rme-2016-0152 ↗
17. Organ-on-chip models of cancer metastasis for future personalized medicine: from chip to the patient10.1016/j.biomaterials.2017.10.005 ↗
18. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform10.1016/j.actbio.2020.02.015 ↗
19. Synergistic engineering: organoids meet organs-on-a-chip10.1016/j.stem.2017.08.016 ↗
20. Personalized cancer medicine: an organoid approach10.1016/j.tibtech.2017.12.005 ↗
21. Microfluidic 3D models of cancer10.1016/j.addr.2014.07.002 ↗
22. The human gut microbiome—a potential controller of wellness and disease10.3389/fmicb.2018.01835 ↗
23. A microfluidics-based in vitro model of the gastrointestinal human-microbe interface10.1038/ncomms11535 ↗
24. Host–microbiota maladaptation in colorectal cancer10.1038/s41586-020-2729-3 ↗
25. What can microfluidics do for human microbiome research?10.1063/5.0012185 ↗
26. Engineering 3D hydrogels for personalized in vitro human tissue models10.1002/adhm.201701165 ↗
27. Organoids in cancer research10.1038/s41568-018-0007-6 ↗
28. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium10.1053/j.gastro.2011.07.050 ↗
29. Organ-on-chip approaches for intestinal 3D in vitro modeling10.1016/j.jcmgh.2021.08.015 ↗
30. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids10.1016/j.jhep.2019.06.030 ↗
31. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation10.1038/nprot.2016.097 ↗
32. Organoid culture systems for prostate epithelial and cancer tissue10.1038/nprot.2016.006 ↗
33. Assessment of genetic drift in large pharmacogenomic studies10.1016/j.cels.2020.08.012 ↗
34. A serial analysis of gene expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue origins10.1158/0008-5472.CAN-03-3383 ↗
35. CRISPR/Cas 9 genome editing and its applications in organoids10.1152/ajpgi.00410.2016 ↗
36. Intestinal multicellular organoids to study colorectal cancer10.1016/j.bbcan.2021.188586 ↗
37. Prospective derivation of a living organoid biobank of colorectal cancer patients10.1016/j.cell.2015.03.053 ↗
38. World cancer report 2020
39. Colorectal cancer10.1038/nrdp.2015.65 ↗
40. A 3D view of colorectal cancer models in predicting therapeutic responses and resistance10.3390/cancers13020227 ↗
41. Tales from the crypt: intestinal niche signals in tissue renewal, plasticity and cancer10.1098/rsob.180120 ↗
42. The paneth cell: the curator and defender of the immature small intestine10.3389/fimmu.2020.00587 ↗
43. Diet, microbiota, and colorectal cancer10.1016/j.isci.2019.10.011 ↗
44. CSN8 is a key regulator in hypoxia-induced epithelial–mesenchymal transition and dormancy of colorectal cancer cells10.1186/s12943-020-01285-4 ↗
45. Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?10.1016/j.jacbts.2019.10.008 ↗
46. Animal models of human colorectal cancer: current status, uses and limitations10.3748/wjg.v21.i41.11854 ↗
47. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche10.1038/nature07935 ↗
48. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer10.1038/s41586-021-03525-z ↗
49. Apc-mutant cells act as supercompetitors in intestinal tumour initiation10.1038/s41586-021-03558-4 ↗
50. Changes in extracellular matrix in different stages of colorectal cancer and their effects on proliferation of cancer cells10.4251/WJGO.V12.I3.267 ↗
51. Cancer-associated fibroblasts and desmoplastic reactions related to cancer invasiveness in patients with colorectal cancer10.3393/ac.2018.09.10 ↗
52. Physical traits of cancer10.1126/science.aaz0868.Physical ↗
53. Simulating the human colorectal cancer microenvironment in 3D tumor-stroma co-cultures in vitro in vivo10.1038/s41598-020-66785-1 ↗
54. Effects of extracellular matrix viscoelasticity on cellular behaviour10.1038/s41586-020-2612-2 ↗
55. Proteinaceous hydrogels for bioengineering advanced 3D tumor models10.1002/advs.202003129 ↗
56. Engineering the extracellular matrix to model the evolving tumor microenvironment10.1016/j.isci.2020.101742 ↗
57. 3D bioprinting for reconstituting the cancer microenvironment10.1038/s41698-020-0121-2 ↗
58. 3D printed in vitro tumor tissue model of colorectal cancer10.7150/thno.52450 ↗
59. Endothelial cells in colorectal cancer10.4251/wjgo.v11.i11.946 ↗
60. Circulating endothelial cells and their subpopulations: role as predictive biomarkers in antiangiogenic therapy for colorectal cancer10.1016/j.clcc.2014.12.002 ↗
61. 3D microtumors in vitro supported by perfused vascular networks10.1038/srep31589 ↗
62. Hallmarks of cancer: the next generation10.1016/j.cell.2011.02.013 ↗
63. CAR t-cell therapy in hematological malignancies10.3390/ijms22168996 ↗
64. 3D model for CAR ‐mediated cytotoxicity using patient‐derived colorectal cancer organoids10.15252/embj.2018100928 ↗
65. Metabolic and epigenetic regulation of T-cell exhaustion10.1038/s42255-020-00280-9 ↗
66. Optimization of metabolism to improve efficacy during CAR-T cell manufacturing10.1186/s12967-021-03165-x ↗
67. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling10.1016/j.drudis.2016.07.003 ↗
68. Clinical development success rates for investigational drugs10.1038/nbt.2786 ↗
69. A 3D printed hanging drop dripper for tumor spheroids analysis without recovery10.1038/s41598-019-56241-0 ↗
70. Co-culture of tumor spheroids and fibroblasts in a collagen matrix-incorporated microfluidic chip mimics reciprocal activation in solid tumor microenvironment10.1371/journal.pone.0159013 ↗
71. Co-culture of 3D tumor spheroids with fibroblasts as a model for epithelial-mesenchymal transition in vitro10.1016/j.yexcr.2015.05.016 ↗
72. Improving drug delivery to solid tumors: priming the tumor microenvironment10.1016/j.jconrel.2014.12.018 ↗
73. Physical characterization of colorectal cancer spheroids and evaluation of NK cell infiltration through a flow-based analysis10.3389/fimmu.2020.564887 ↗
74. Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response10.1038/s42003-021-02526-y ↗
75. A microfluidic spheroid culture device with a concentration gradient generator for high-throughput screening of drug efficacy10.3390/molecules23123355 ↗
76. Single and combination drug screening with aqueous biphasic tumor spheroids10.1177/2472555217698817 ↗
77. Engineered microphysiological systems for testing effectiveness of cell-based cancer immunotherapies10.3390/cancers14153561 ↗
78. High-throughput microfluidics for evaluating microbubble enhanced delivery of cancer therapeutics in spheroid cultures10.1016/j.jconrel.2020.06.011 ↗
79. Doxorubicin-bound albumin nanoparticles containing a TRAIL protein for targeted treatment of colon cancer10.1007/s11095-015-1814-z ↗
80. Nanoparticle albumin—bound (NAB) technology is a promising method for anti-cancer drug delivery10.2174/157489209789206869 ↗
81. A colorectal cancer 3D bioprinting workflow as a platform for disease modeling and chemotherapeutic screening10.3389/fbioe.2021.755563 ↗
82. Colorectal cancer triple co-culture spheroid model to assess the biocompatibility and anticancer properties of polymeric nanoparticles10.1016/j.jconrel.2020.04.025 ↗
83. Microfluidic device flow field characterization around tumor spheroids with tunable necrosis produced in an optimized off-chip process10.1007/s10544-017-0200-5 ↗
84. Multi-omics of 34 colorectal cancer cell lines—a resource for biomedical studies10.1186/s12943-017-0691-y ↗
85. Next-generation cancer organoids10.1038/s41563-021-01057-5 ↗
86. Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing10.1038/nm.4355 ↗
87. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation10.1038/s41467-020-19173-2 ↗
88. Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling10.1038/s41556-021-00654-5 ↗
89. Establishment of colorectal cancer organoids in microfluidic-based system10.3390/mi12050497 ↗
90. Tumour heterogeneity and resistance to cancer therapies10.1038/nrclinonc.2017.166 ↗
91. Intra-tumour diversification in colorectal cancer at the single-cell level10.1038/s41586-018-0024-3 ↗
92. Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ10.1038/s41467-021-22544-y ↗
93. Cell-type-specific signaling networks in heterocellular organoids10.1038/s41592-020-0737-8 ↗
94. Hydrogel-based colorectal cancer organoid co-culture models10.1016/j.actbio.2020.12.037 ↗
95. Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer10.1016/j.cell.2019.05.012 ↗
96. Homeostatic mini-intestines through scaffold-guided organoid morphogenesis10.1038/s41586-020-2724-8 ↗
97. Enabling peristalsis of human colon tumor organoids on microfluidic chips10.1088/1758-5090/ac2ef9 ↗
98. Tissue geometry drives deterministic organoid patterning10.1126/science.aaw9021 ↗
99. The clonal evolution of tumor cell populations10.1126/science.959840 ↗
100. 5-fluorouracil: mechanisms of action and clinical strategies10.1038/nrc1074 ↗